186 related articles for article (PubMed ID: 31704819)
41. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
[TBL] [Abstract][Full Text] [Related]
42. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
43. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
44. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
[TBL] [Abstract][Full Text] [Related]
45. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
[TBL] [Abstract][Full Text] [Related]
46. Genome-wide screening and co-expression network analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma.
Lin ZW; Gu J; Liu RH; Liu XM; Xu FK; Zhao GY; Lu CL; Ge D
Tumour Biol; 2014 Nov; 35(11):10959-68. PubMed ID: 25087095
[TBL] [Abstract][Full Text] [Related]
47. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
[TBL] [Abstract][Full Text] [Related]
48. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma.
Zhang SS; Xie X; Wen J; Luo KJ; Liu QW; Yang H; Hu Y; Fu JH
Diagn Pathol; 2016 Jan; 11():14. PubMed ID: 26818094
[TBL] [Abstract][Full Text] [Related]
49. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
[TBL] [Abstract][Full Text] [Related]
50. A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
Peng L; Guo JC; Long L; Pan F; Zhao JM; Xu LY; Li EM
Biomed Res Int; 2019; 2019():3869825. PubMed ID: 31815134
[TBL] [Abstract][Full Text] [Related]
51. NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma.
Wu X; Lim ZF; Li Z; Gu L; Ma W; Zhou Q; Su H; Wang X; Yang X; Zhang Z
Oncol Res Treat; 2017; 40(6):370-374. PubMed ID: 28482344
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH
Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518
[TBL] [Abstract][Full Text] [Related]
53. Investigation of melanoma-associated antigen A4 cancer/testis antigen clinical relevance in esophageal squamous cell carcinoma.
Sani SA; Forghanifard MM; Sharifi N; Bidokhti MH; Bagherpoor AJ; Abbaszadegan MR
J Cancer Res Ther; 2018; 14(5):1059-1064. PubMed ID: 30197348
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
Wang S; Wang Z; Liu X; Yang Y; Shi M; Sun Z
Tumour Biol; 2015 Aug; 36(8):6181-9. PubMed ID: 25758053
[TBL] [Abstract][Full Text] [Related]
55. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
56. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
57. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
[TBL] [Abstract][Full Text] [Related]
58. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
59. FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.
Islam F; Gopalan V; Law S; Tang JC; Lam AK
Hum Pathol; 2019 May; 87():1-10. PubMed ID: 30794892
[TBL] [Abstract][Full Text] [Related]
60. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
